Imexpharm Corp
VN:IMP
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
24 572.8953
53 200
|
Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Imexpharm Corp
Total Current Liabilities
Imexpharm Corp
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Imexpharm Corp
VN:IMP
|
Total Current Liabilities
â‚«427.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
16%
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Total Current Liabilities
â‚«593.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Total Current Liabilities
â‚«618.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Total Current Liabilities
â‚«455.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
12%
|
CAGR 10-Years
3%
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Total Current Liabilities
â‚«1.8T
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
T
|
Traphaco JSC
VN:TRA
|
Total Current Liabilities
â‚«472.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
8%
|
See Also
What is Imexpharm Corp's Total Current Liabilities?
Total Current Liabilities
427.3B
VND
Based on the financial report for Jun 30, 2024, Imexpharm Corp's Total Current Liabilities amounts to 427.3B VND.
What is Imexpharm Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
16%
Over the last year, the Total Current Liabilities growth was -26%. The average annual Total Current Liabilities growth rates for Imexpharm Corp have been -1% over the past three years , 3% over the past five years , and 16% over the past ten years .